Drug:
Reaction: INJECTION SITE PAIN
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491714 |
US |
32 | 1 |
Incorrect route of product administration, Injection site mass, Injection site swelling, Injection site pain, |
||||
NALTREXONE, |
||||
| 2 | 25491726 |
US |
55 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 3 | 25491728 |
US |
57 | 2 |
Injection site pain, Injection site mass, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 4 | 25491729 |
US |
46 | 2 |
Headache, Memory impairment, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 5 | 25491764 |
US |
57 | 2 |
Extra dose administered, Feeling abnormal, Feeling hot, Blood glucose increased, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 6 | 25491815 |
EG |
5 | 1 |
Injection site pain, Off label use, Drug administered in wrong device, Product substitution issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 7 | 25491818 |
US |
16 | 1 |
Burning sensation, Condition aggravated, Injection site pain, Rash, |
||||
DUPILUMAB, |
||||
| 8 | 25491838 |
US |
67 | |
Product dose omission issue, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 9 | 25491898 |
US |
2 | |
Injection site discolouration, Injection site pain, Injection site induration, |
||||
DUPILUMAB, |
||||
| 10 | 25491913 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 11 | 25491954 |
US |
36 | 2 |
Injection site haemorrhage, Injection site pain, |
||||
GALCANEZUMAB-GNLM, |
||||
| 12 | 25491955 |
US |
24 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, |
||||
| 13 | 25492007 |
US |
73 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 14 | 25492135 |
US |
64 | 2 |
Injection site bruising, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 15 | 25492136 |
US |
50 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 16 | 25492198 |
US |
38 | 2 |
Injection site pain, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 17 | 25492199 |
US |
35 | 1 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 18 | 25492201 |
US |
42 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 19 | 25492292 |
US |
66 | 1 |
Injection site haemorrhage, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 20 | 25492456 |
US |
54 | 2 |
Ankle fracture, Injection site urticaria, Injection site pain, |
||||
DUPILUMAB, |
||||
| 21 | 25492515 |
US |
47 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 22 | 25492521 |
US |
47 | 2 |
Injection site pain, |
||||
GUSELKUMAB, |
||||
| 23 | 25492647 |
US |
||
Injection site pain, |
||||
DULAGLUTIDE, |
||||
| 24 | 25493007 |
US |
63 | 2 |
Injury associated with device, Product administered at inappropriate site, Wrong technique in product usage process, Incorrect dose administered, Injection site swelling, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 25 | 25493009 |
US |
50 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 26 | 25493401 |
US |
||
Multiple use of single-use product, Injection site pain, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 27 | 25493487 |
US |
78 | 2 |
Accidental underdose, Neuropathy peripheral, Injection site pain, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 28 | 25493506 |
US |
81 | 2 |
Device difficult to use, Drug dose omission by device, Injection site pain, |
||||
EVOLOCUMAB, |
||||
| 29 | 25493529 |
US |
13 | 1 |
Injection site pain, Injection site discharge, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 30 | 25493735 |
US |
74 | 2 |
Fungal infection, Injection site pain, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 31 | 25493737 |
US |
50 | 2 |
Injection site pain, Pain, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, MELOXICAM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 32 | 25493774 |
US |
2 | |
Cerebrovascular accident, Illness, Product colour issue, Injection site pain, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 33 | 25493916 |
CA |
18 | 1 |
Injection site pain, |
||||
ADALIMUMAB-AFZB, |
||||
| 34 | 25493932 |
CA |
62 | 2 |
Pneumonia fungal, Treatment failure, Injection site bruising, Injection site pain, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 35 | 25493961 |
US |
60 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, INSULIN ASPART, INSULIN DEGLUDEC, |
||||
| 36 | 25493966 |
US |
50 | 2 |
Headache, Injection site pain, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 37 | 25494132 |
US |
79 | 1 |
Mobility decreased, Electrolyte depletion, Mineral deficiency, Diarrhoea, Asthenia, Balance disorder, Injection site hypoaesthesia, Injection site pain, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 38 | 25494150 |
US |
2 | |
Sensory disturbance, Injury associated with device, Wrong patient received product, Accidental exposure to product, Device use error, Injection site pain, Injection site swelling, |
||||
EVOLOCUMAB, |
||||
| 39 | 25494200 |
US |
1 | |
Injection site pain, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 40 | 25494352 |
US |
1 | |
Injection site pain, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 41 | 25494588 |
US |
43 | 1 |
Injection site pain, Gait disturbance, Nerve injury, Pain in extremity, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 42 | 25494871 |
US |
13 | 1 |
Injection site pain, Device difficult to use, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 43 | 25494961 |
US |
64 | 2 |
Injection site pain, |
||||
DULAGLUTIDE, |
||||
| 44 | 25495234 |
US |
49 | 1 |
Device deployment issue, Product dose omission issue, Injection site pain, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 45 | 25495309 |
US |
71 | 2 |
Injection site pain, Injection site mass, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 46 | 25495312 |
US |
67 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 47 | 25495325 |
US |
62 | |
Injection site pain, Extra dose administered, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 48 | 25495461 |
US |
1 | |
Injection site pain, Device difficult to use, Device leakage, Device breakage, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 49 | 25495578 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 50 | 25495583 |
US |
14 | 2 |
Injection site pain, Injection site erythema, Injection site swelling, Product use in unapproved indication, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 51 | 25495607 |
US |
66 | 1 |
Rash, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 52 | 25495623 |
US |
14 | 1 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 53 | 25495648 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 54 | 25495673 |
US |
82 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 55 | 25495675 |
US |
11 | 2 |
Injection site swelling, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 56 | 25495684 |
US |
65 | 1 |
Injection site erythema, Condition aggravated, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 57 | 25495693 |
US |
73 | 2 |
Abdominal pain upper, Rash pruritic, Vision blurred, Injection site pain, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 58 | 25495724 |
US |
65 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 59 | 25495771 |
US |
45 | 1 |
Eczema, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 60 | 25495774 |
US |
69 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 61 | 25495781 |
US |
33 | 1 |
Injection site inflammation, Injection site pain, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 62 | 25495785 |
US |
56 | 2 |
Injection site urticaria, Injection site pruritus, Injection site swelling, Injection site pain, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 63 | 25495811 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST SODIUM, MONTELUKAST, DOXAZOSIN MESYLATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, FLUTICASONE PROPIONATE, MUPIROCIN, MUPIROCIN CALCIUM, OXYCODONE, AZELASTINE, VALSARTAN AND HYDROCHLOROTHIAZIDE, |
||||
| 64 | 25495813 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 65 | 25495825 |
US |
36 | 2 |
Injection site pain, Lack of injection site rotation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 66 | 25495829 |
US |
64 | 1 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 67 | 25495842 |
US |
61 | 2 |
Dry mouth, Injection site pain, |
||||
DUPILUMAB, |
||||
| 68 | 25495854 |
US |
51 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 69 | 25495855 |
US |
62 | 1 |
Injection site pain, Product preparation error, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 70 | 25495856 |
US |
33 | 2 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 71 | 25495857 |
US |
28 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 72 | 25495872 |
US |
80 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 73 | 25495874 |
US |
56 | 1 |
Dry skin, Pruritus, Injection site pain, Product preparation error, |
||||
DUPILUMAB, |
||||
| 74 | 25495875 |
US |
78 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 75 | 25495927 |
US |
68 | 1 |
Injection site warmth, Injection site pain, |
||||
DUPILUMAB, MOMETASONE FUROATE, ALBUTEROL SULFATE, |
||||
| 76 | 25495928 |
US |
42 | 2 |
Dyspnoea, Injection site pain, |
||||
DUPILUMAB, |
||||
| 77 | 25495941 |
US |
40 | 1 |
Injection site pain, Injection site erythema, Injection site swelling, Injection site urticaria, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 78 | 25495979 |
AR |
51 | 2 |
Asthmatic crisis, Rash, Injection site pain, Fear of injection, Illness, Food allergy, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 79 | 25496000 |
US |
46 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 80 | 25496013 |
US |
63 | 2 |
Rheumatoid arthritis, Injection site pain, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, DENOSUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 81 | 25496066 |
US |
2 | |
Glycosylated haemoglobin increased, Feeding disorder, Weight increased, Eructation, Constipation, Flatulence, Gastrooesophageal reflux disease, Nausea, Fatigue, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 82 | 25496098 |
US |
51 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 83 | 25496127 |
US |
||
Injection site reaction, Injection site pain, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 84 | 25496273 |
US |
1 | |
Lack of administration site rotation, Intentional dose omission, Injection site mass, Injection site induration, Injection site pain, |
||||
NALTREXONE, |
||||
| 85 | 25496304 |
US |
63 | 1 |
Incorrect dose administered, Nausea, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 86 | 25496347 |
US |
21 | 2 |
Injection site pain, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 87 | 25496663 |
US |
78 | 2 |
Migraine, Cervix disorder, Reflexes abnormal, Injection site pain, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, RIMEGEPANT SULFATE, |
||||
| 88 | 25490984 |
US |
2 | |
Injection site erythema, Injection site pain, |
||||
DUPILUMAB, VALBENAZINE, FISH OIL, NIACIN, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TIRZEPATIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, THYROID, IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,, THYROID, UNSPECIFIED, DAPAGLIFLOZIN, PROGESTERONE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, TIZANIDINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, CLONAZEPAM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUOXETINE HYDROCHLORIDE, |
||||
| 89 | 25490991 |
US |
2 | |
Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, BUSPIRONE HYDROCHLORIDE, BUTALBITAL AND ACETAMINOPHEN, BUTALBITAL AND ACETAMINOPHEN TABLETS, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, IPRATROPIUM BROMIDE AND ALBUTEROL, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, HYDROXYZINE, ISOSORBIDE MONONITRATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LISINOPRIL, LORAZEPAM, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREGABALIN, PROMETHAZINE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 90 | 25490993 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 91 | 25491026 |
US |
2 | |
Injection site pain, Cough, Throat irritation, Sneezing, Product use in unapproved indication, |
||||
DUPILUMAB, ATENOLOL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, HYDROCHLOROTHIAZIDE, MONTELUKAST, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SERTRALINE HYDROCHLORIDE, |
||||
| 92 | 25491029 |
US |
2 | |
Nasal congestion, Migraine, Myalgia, Back pain, Nasopharyngitis, Cough, Arthralgia, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, BUSPIRONE HYDROCHLORIDE, BUTALBITAL AND ACETAMINOPHEN, BUTALBITAL AND ACETAMINOPHEN TABLETS, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, IPRATROPIUM BROMIDE AND ALBUTEROL, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, HYDROXYZINE, ISOSORBIDE MONONITRATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LISINOPRIL, LORAZEPAM, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREGABALIN, PROMETHAZINE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 93 | 25491044 |
US |
64 | 2 |
Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 94 | 25491083 |
US |
60 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 95 | 25491086 |
US |
25 | |
Injection site erythema, Injection site pain, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 96 | 25491092 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 97 | 25491099 |
US |
78 | 1 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 98 | 25491110 |
US |
58 | 1 |
Dermatitis atopic, Injection site bruising, Injection site pain, |
||||
DUPILUMAB, |
||||
| 99 | 25491125 |
US |
66 | 2 |
Injection site pain, Product preparation error, Eye swelling, Eye pruritus, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, CARVEDILOL, LOSARTAN POTASSIUM, LOSARTAN, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, METOLAZONE, |
||||
| 100 | 25491137 |
US |
42 | 2 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29